Park Ha Biological Technology (BYAH) Equity Ratio (2023 - 2025)

Park Ha Biological Technology (BYAH) recorded quarterly Equity Ratio of 0.67 in Q4 2025, up 50.12% quarter-over-quarter from 0.45 in Q4 2023.

Park Ha Biological Technology (BYAH) Equity Ratio (2023 - 2025) Analysis & Trends

Park Ha Biological Technology's Equity Ratio history runs 2 years deep, the most recent figure standing at 0.67 for Q4 2025.

In Q4 2025, Equity Ratio changed N/A year-over-year to 0.67; the TTM figure through Oct 2025 stood at 0.67 (changed N/A YoY), while the FY2025 annual figure was 0.67, changed N/A from the prior year.
Equity Ratio was 0.67 for Q4 2025 at Park Ha Biological Technology, up from 0.45 in the prior quarter.
In the past five years, Equity Ratio ranged from a high of 0.67 in Q4 2025 to a low of 0.45 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Ratio (Qtr)
1	Tantech Holdings	587.03 Bn	587.00 Bn	-	0.85
2	Procter & Gamble	346.82 Bn	334.74 Bn	10.51 Bn	0.43
3	Unilever	145.94 Bn	135.46 Bn	-	0.22
4	Colgate Palmolive	70.39 Bn	69.40 Bn	3.23 Bn	0.03
5	Kenvue	34.34 Bn	34.23 Bn	2.30 Bn	0.40
6	Kimberly Clark	33.38 Bn	32.96 Bn	1.53 Bn	0.11
7	Estee Lauder Companies	31.47 Bn	28.34 Bn	2.84 Bn	0.20
8	Church & Dwight	22.92 Bn	22.42 Bn	681.40 Mn	0.46
9	Clorox	11.90 Bn	10.87 Bn	722.00 Mn	0.01
10	Park Ha Biological Technology	912,742.27	-2.87 Mn	-	0.67

Download Data

Date	Value
Oct 31, 2025	0.67
Oct 31, 2023	0.45